LivaNova (LIVN) Cash & Equivalents (2016 - 2026)
LivaNova's Cash & Equivalents history spans 12 years, with the latest figure at $646.1 million for Q3 2025.
- On a quarterly basis, Cash & Equivalents rose 101.77% to $646.1 million in Q3 2025 year-over-year; TTM through Sep 2025 was $646.1 million, a 101.77% increase, with the full-year FY2024 number at $428.9 million, up 60.92% from a year prior.
- Cash & Equivalents hit $646.1 million in Q3 2025 for LivaNova, down from $738.4 million in the prior quarter.
- Over the last five years, Cash & Equivalents for LIVN hit a ceiling of $738.4 million in Q1 2025 and a floor of $181.8 million in Q3 2021.
- Historically, Cash & Equivalents has averaged $337.1 million across 5 years, with a median of $306.5 million in 2024.
- Biggest five-year swings in Cash & Equivalents: fell 25.11% in 2023 and later surged 140.93% in 2025.
- Tracing LIVN's Cash & Equivalents over 5 years: stood at $181.8 million in 2021, then rose by 17.78% to $214.2 million in 2022, then rose by 24.43% to $266.5 million in 2023, then skyrocketed by 60.92% to $428.9 million in 2024, then surged by 50.65% to $646.1 million in 2025.
- Business Quant data shows Cash & Equivalents for LIVN at $646.1 million in Q3 2025, $738.4 million in Q1 2025, and $428.9 million in Q4 2024.